State Street Corp Arcturus Therapeutics Holdings Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, State Street Corp holds 1,472,955 shares of ARCT stock, worth $27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,472,955

Previous 1,523,838 3.34%

Holding current value

$27 Million

Previous $37.1 Million 7.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $919,964 - $1.29 Million	-50,883 Reduced 3.34%	1,472,955 $34.2 Million
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $10.6 Million - $19.4 Million	-436,098 Reduced 22.25%	1,523,838 $37.1 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $10.3 Million - $14.2 Million	330,270 Added 20.27%	1,959,936 $66.2 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $677,566 - $1.26 Million	-38,259 Reduced 2.29%	1,629,666 $51.4 Million
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $8.05 Million - $11.8 Million	-316,243 Reduced 15.94%	1,667,925 $42.6 Million
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $6.08 Million - $8.21 Million	-253,831 Reduced 11.34%	1,984,168 $56.9 Million
Q1 2023 May 15, 2023	SELL	$14.72 - $23.97 $292,147 - $475,732	-19,847 Reduced 0.88%	2,237,999 $53.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.14 - $23.06 $6.68 Million - $10.9 Million	-472,616 Reduced 17.31%	2,257,846 $38.3 Million
Q3 2022 Nov 15, 2022	SELL	$13.05 - $22.13 $997,750 - $1.69 Million	-76,456 Reduced 2.72%	2,730,462 $40.5 Million
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $5.04 Million - $12.8 Million	-411,039 Reduced 12.77%	2,806,918 $44.2 Million
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $20.5 Million - $46 Million	1,161,883 Added 56.51%	3,217,957 $86.8 Million
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $20 Million - $27.9 Million	585,733 Added 39.84%	2,056,074 $76.1 Million
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $7.95 Million - $16.6 Million	-285,313 Reduced 16.25%	1,470,341 $70.3 Million
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $9.22 Million - $15.1 Million	357,619 Added 25.58%	1,755,654 $59.4 Million
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $15 Million - $33.6 Million	386,116 Added 38.16%	1,398,035 $57.7 Million
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $19 Million - $67.8 Million	-548,335 Reduced 35.14%	1,011,919 $43.9 Million
Q3 2020 Nov 10, 2020	BUY	$37.49 - $63.19 $48.8 Million - $82.3 Million	1,302,232 Added 504.7%	1,560,254 $66.9 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $3.27 Million - $15 Million	258,022 New	258,022 $12.1 Million

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.7M

Call Options Held

283K

Put Options Held

87.5K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $487M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Arcturus Therapeutics Holdings Inc. Transaction History